Aytu Biopharma Inc (AYTU) Stock Price, Quote & News

Company Profile

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above, and Cotempla XR-ODT extended-release orally disintegrating tablets for patients from six to seventeen years old. It also provides pedia...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: (720) 437-6580

Website: aytubio.com

Address:

Denver Corporate Center III, Suite 920 7900 East Union Avenue, Denver, United States

RowdySquire Jul. 6 at 4:17 AM

Accumulating $AYTU 🤌

0 · Reply

Doozio Jul. 4 at 3:54 PM

$AYTU 🧠⏰ didn’t include biotechs. Bahhhht 🐒🍌🧠⏰♾️ wUll!

0 · Reply

alienmx Jul. 4 at 3:13 PM

Been proudly bagholding $AYTU since 2021 at an average price of $153, thanks to a generous series of reverse splits. Just ran a deep forensic autopsy with GPT-o3 on this masterpiece. Enjoy! https://chatgpt.com/s/dr_6867ee3699d48191a5f5c96177ebf6d9

1 · Reply

timzip Jul. 4 at 9:30 AM

$AYTU This is one of the indicators I use to assess market top. Perhaps one of the most reliable ones.

0 · Reply

Dr_Pansen Jul. 4 at 8:52 AM

$AYTU i am back at aytu. Was invested long ago but needed to buy a house. Whats going on here? I saw mc decreased dramatically. What happened? Many offerings and no still no profit? Is there some light at horizon?

0 · Reply

termoil Jul. 3 at 7:27 PM

$AYTU Wow were on fire today!!TEN Cents up peeps!!Slow but steady mates!!

0 · Reply

mm2270 Jul. 3 at 2:10 PM

$AYTU Josh loves you 😘

0 · Reply

Encept Jul. 3 at 1:14 PM

$AYTU

0 · Reply

cashmeupside Jul. 3 at 12:06 PM

$AYTU

0 · Reply

termoil Jul. 2 at 7:45 PM

$AYTU

0 · Reply

Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)

Jun 23, 2025, 8:00 AM EDT - 14 days ago

Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)

Jun 9, 2025, 4:30 PM EDT - 4 weeks ago

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Jun 6, 2025, 8:01 AM EDT - 4 weeks ago

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

Jun 6, 2025, 8:00 AM EDT - 4 weeks ago

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

May 14, 2025, 8:29 PM EDT - 7 weeks ago

Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Call Transcript

May 14, 2025, 4:05 PM EDT - 7 weeks ago

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

May 7, 2025, 4:15 PM EDT - 2 months ago

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

Apr 21, 2025, 4:05 PM EDT - 2 months ago

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Feb 12, 2025, 6:27 PM EST - 5 months ago

Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript

Feb 12, 2025, 4:03 PM EST - 5 months ago

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Feb 5, 2025, 5:50 PM EST - 5 months ago

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

Jan 6, 2025, 9:00 AM EST - 6 months ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Dec 3, 2024, 11:45 PM EST - 7 months ago

Aytu BioPharma Disclosure Notification

Nov 22, 2024, 9:00 AM EST - 8 months ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Nov 13, 2024, 7:25 PM EST - 8 months ago

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Nov 13, 2024, 4:05 PM EST - 8 months ago

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Nov 6, 2024, 5:20 PM EST - 8 months ago

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Oct 14, 2024, 4:15 PM EDT - 9 months ago

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 1, 2024, 8:00 AM EDT - 9 months ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Sep 26, 2024, 6:51 PM EDT - 10 months ago

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Sep 26, 2024, 4:15 PM EDT - 10 months ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Sep 19, 2024, 5:30 PM EDT - 10 months ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Aug 8, 2024, 5:20 PM EDT - 11 months ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aug 6, 2024, 8:00 AM EDT - 11 months ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Jun 18, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

May 15, 2024, 8:28 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

May 15, 2024, 4:05 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

May 8, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Apr 3, 2024, 9:00 AM EDT - 1 year ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Feb 14, 2024, 10:52 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Feb 14, 2024, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Feb 7, 2024, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Jan 23, 2024, 9:00 AM EST - 1 year ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Nov 30, 2023, 8:00 AM EST - 1 year ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Nov 14, 2023, 7:30 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Nov 14, 2023, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 8, 2023, 8:30 AM EST - 1 year ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Nov 7, 2023, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Oct 26, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Oct 9, 2023, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Sep 27, 2023, 7:01 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Sep 27, 2023, 4:20 PM EDT - 1 year ago

Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Sep 21, 2023, 8:25 PM EDT - 1 year ago

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Sep 13, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Jul 31, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority

Jul 10, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Jun 14, 2023, 8:00 AM EDT - 2 years ago

Aytu to Participate in the Maxim Group Virtual Healthcare Conference

Jun 13, 2023, 1:45 PM EDT - 2 years ago

Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market

Jun 9, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

RowdySquire Jul. 6 at 4:17 AM

Accumulating $AYTU 🤌

0 · Reply

Doozio Jul. 4 at 3:54 PM

$AYTU 🧠⏰ didn’t include biotechs. Bahhhht 🐒🍌🧠⏰♾️ wUll!

0 · Reply

alienmx Jul. 4 at 3:13 PM

1 · Reply

timzip Jul. 4 at 9:30 AM

$AYTU This is one of the indicators I use to assess market top. Perhaps one of the most reliable ones.

0 · Reply

Dr_Pansen Jul. 4 at 8:52 AM

0 · Reply

termoil Jul. 3 at 7:27 PM

$AYTU Wow were on fire today!!TEN Cents up peeps!!Slow but steady mates!!

0 · Reply

mm2270 Jul. 3 at 2:10 PM

$AYTU Josh loves you 😘

0 · Reply

Encept Jul. 3 at 1:14 PM

$AYTU

0 · Reply

cashmeupside Jul. 3 at 12:06 PM

$AYTU

0 · Reply

termoil Jul. 2 at 7:45 PM

$AYTU

0 · Reply

ackerman2436 Jul. 2 at 3:42 PM

$AYTU Chart looks pretty damn good....

0 · Reply

mm2270 Jul. 2 at 3:16 PM

$AYTU I’m so proud to own a part of this wonderful company. It’s heartwarming to know Josh has always looked out for us retail. 😂 🚀🚀🚀🚀🚀🚀🚀🚀

0 · Reply

Invest2live Jul. 1 at 8:57 PM

$AYTU congrats 🌿🎉🎊; if you loaded the AYTU at or below 2.

1 · Reply

Dolphinsarecute Jul. 1 at 7:02 PM

$AYTU In with all my life savings. This will reach 300 by Friday. With such a handsome and honest CEO, no doubt.

1 · Reply

WaspofWallStreet Jul. 1 at 6:02 PM

$AYTU Opened new position. This may have some short-term replacement will look to continue to add on dips if applicable.

0 · Reply

ackerman2436 Jul. 1 at 2:07 PM

$AYTU Golden cross inbound, 12 dollar target, 8 dollar target. Over all moving averages, positive operation income, now flush with cash, low float, is this happening for real? Took a small position at 2.2, let's see how this plays out. GLTA bulls

0 · Reply

mm2270 Jul. 1 at 1:24 PM

$AYTU World Renowned Lake Street with a Buy rating….right on the cusp of the golden cross. 🤷‍♂️🤷‍♂️🤷‍♂️🤷‍♂️

0 · Reply

Wildsens Jun. 30 at 9:21 PM

$AYTU PR https://feeds.issuerdirect.com/news-release.html?newsid=8124692436679978&symbol=AYTU

0 · Reply

termoil Jun. 30 at 7:24 PM

$AYTU

0 · Reply

_www_larval_com_ Jun. 30 at 3:48 PM

$AYTU just turned -7% lower to 4% (~645Kv) a few minutes ago, follow for more volatility.

0 · Reply

pietroilbullo Jun. 30 at 2:50 PM

$AYTU

0 · Reply

LeopoldRothschild Jun. 30 at 2:38 PM

$AYTU My price target here is 50 mexican villas.

0 · Reply

Market Cap	21.41M
Revenue (ttm)	81.00M
Net Income (ttm)	-15.84M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.56%
Debt to Equity Ratio	0.61

Volume	143,100
Avg Vol	1,767,028
Day's Range	N/A - N/A
Shares Out	8.98M
Stochastic %K	79%
Beta	0.13
Analysts	Strong Sell
Price Target	$9.33